BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 24, 2019
View Archived Issues
Parkinson's drug inhibits obesity gene
Read More
Novel mouse model of human acute myeloid leukemia with autologous immune system
Read More
Researchers create animal model of orthopedic injury-induced hypercoagulability
Read More
Identification of selective, orally active RORgammat inverse agonists
Read More
Positive initial phase II data for nomacopan in bullous pemphigoid
Read More
Tracon Pharmaceuticals initiates phase I study of TJ-004309 in combination with atezolizumab
Read More
New blood test developed for early Alzheimer's diagnosis
Read More
Yuhan presents preclinical data for its novel anti-TIGIT antibody, YH-29143
Read More
Sunshine Lake Pharma divulges 5-HT1A receptor agonists
Read More
Nanjing TransThera Biosciences patents PDE9 inhibitors
Read More
Preclinical characterization of humanized anti-MERTK monoclonal antibody, RGX-019
Read More
MGL inhibitors revealed in Takeda Pharmaceutical patent
Read More
Phase I data reported for RO-7049389 in patients with chronic HBV infection
Read More
MET-409 is safe and well tolerated in phase I study in healthy male subjects
Read More
Beijing Yuezhikangtai Biomedicines identifies hedgehog-signaling inhibitors
Read More
Fujifilm presents new antibacterials
Read More
Preclinical characterization detailed for phase I cancer candidate S-64315/MIK-665
Read More
Takeda communicates data on ART-648 in preclinical models of NASH
Read More
Innovent begins phase I trial of PD-1/PD-L1 bispecific antibody IBI-318
Read More
Teva discontinues development of fremanezumab for cluster headaches
Read More
Tiziana's phase IIa trial of milciclib in advanced liver cancer passes interim safety review
Read More
FDA approves Skyrizi for moderate to severe plaque psoriasis
Read More
MET/SRC/CSF-1R inhibitor TPX-0022 shows antitumor activity, IND planned
Read More
TC BioPharm conducting phase I study of TCB-002 in AML
Read More